Dr David Spigel talks about currently available and emerging biomarkers that predict the greatest sensitivity to immunotherapy, including his insight into PD-L1, MSI, and TMB.
Get TOP in Your Inbox
Stay up to date with the latest oncology pharmacy news and insights by subscribing to our e-newsletter!